SKN | SELLAS Life Sciences Shares Surge as Cancer Drug Pipeline Boosts Investor Confidence
SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) posted a strong rally on June 26, with shares climbing 17.66% to close at $12.39, while adding...
SKN | Exchange Listed Funds Trust: Expanding the ETF Wrapper as Passive Capital Flows Accelerate
Exchange Listed Funds Trust enters the public markets as a growing ETF platform provider seeking to capitalize on continued structural inflows into passive investment...
SKN | AmperCap Acquisition Company Rights: SPAC Capital Structure Draws Renewed Investor Attention
The planned public offering of AmperCap Acquisition Company Rights enters the market as SPAC-linked instruments regain selective interest among institutional investors seeking structured downside...
SKN | US IPO Market Closes Strong Second Quarter as SpaceX Momentum and AI Volatility Shape Outlook
The US initial public offering market concluded the second quarter of 2026 on a strong note, with robust aftermarket performance and renewed investor confidence...
SKN | Global IPO Weekly Review (June 22–June 26, 2026): Industrial and Technology Filings Sustain US Leadership as Cross-Border Pipeline Expands
Key Points
Successful industrial and mining IPOs shifted institutional capital toward established operating businesses while several smaller issuers continued reducing or withdrawing planned offerings.
...